Add this topic to your myFT Digest for news straight to your inbox
Despite some progress, the fight is a long way from the finish
US regulators have banned imports from 39 laboratories in credibility crisis
Battle to make HIV drugs at a fraction of the cost has helped save millions of lives but made him many enemies
Gilead tries to stop generics for poorer countries going elsewhere
Many of the country’s leading business people are regarded almost as heroes
Domestic producers find conditions in their favour
A new report concludes ignoring ESG considerations will impact profitability
International Edition